RT Book, Section
A1 Mahon, Joseph
A1 McVary, Kevin T.
A2 Bhasin, Shalender
A2 O’Leary, Michael P.
A2 Basaria, Shehzad S.
SR Print(0)
ID 1174516269
T1 Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
T2 Essentials of Men’s Health
YR 2021
FD 2021
PB McGraw Hill
PP New York, NY
SN 9781260135886
LK accessmedicine.mhmedical.com/content.aspx?aid=1174516269
RD 2024/04/19
AB Benign  prostatic  hyperplasia  (BPH)  and  benign  prostatic  hypertrophy  are  often  incorrectly  used  interchangeably.  BPH  is  a  histological  diagnosis  defined  as  an  increase  in  the  total  number  of  prostatic  stromal  cells  and  prostatic  glandular  epithelial  cells  within  the  transition  zone.  As  a  result  of  this  hyperplasia,  large,  discrete,  prostatic  nodules  can  develop.  Benign  prostatic  hypertrophy,  on  the  other  hand,  is  defined  as  an  increase  in  the  size  of  the  individual  prostatic  cells  resulting  in  a  global  enlargement  of  the  prostate  gland  with  no  discrete  nodularity.  Through  a  combination  of  these  two  processes,  benign  prostatic  enlargement  (BPE)  results.  If  BPE  leads  to  obstruction  of  the  bladder  neck  in  the  absence  of  prostate  cancer,  benign  prostatic  obstruction  (BPO)  results.